Aacr.org·2 min read·hard
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)
✦AI Summary
The American Association for Cancer Research reports that a new vaccine designed to prevent pancreatic cancer in high-risk individuals has demonstrated safety and triggered durable immune responses in early testing.
Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in